185 related articles for article (PubMed ID: 33648611)
1. Telephone triage of suspected head and neck cancer patients during the coronavirus disease 2019 pandemic using the Head and Neck Cancer Risk Calculator version 2.
Banerjee S; Voliotidis D; Parvin L; Rama SPK
J Laryngol Otol; 2021 Mar; 135(3):241-245. PubMed ID: 33648611
[TBL] [Abstract][Full Text] [Related]
2. Remote triaging of urgent suspected head and neck cancer referrals: our experience during the first wave of the COVID-19 pandemic.
Kaddour H; Jama GM; Stagnell S; Kaddour S; Guner K; Kumar G
Eur Arch Otorhinolaryngol; 2022 Feb; 279(2):1111-1115. PubMed ID: 34661717
[TBL] [Abstract][Full Text] [Related]
3. Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
Hardman JC; Tikka T; Paleri V;
Cancer; 2021 Nov; 127(22):4177-4189. PubMed ID: 34411287
[TBL] [Abstract][Full Text] [Related]
4. Rapid implementation of an evidence-based remote triaging system for assessment of suspected referrals and patients with head and neck cancer on follow-up after treatment during the COVID-19 pandemic: Model for international collaboration.
Paleri V; Hardman J; Tikka T; Bradley P; Pracy P; Kerawala C
Head Neck; 2020 Jul; 42(7):1674-1680. PubMed ID: 32374942
[TBL] [Abstract][Full Text] [Related]
5. Primary care triaging of head and neck cancer referrals using the head and neck cancer risk calculator version 2: impact on a tertiary head and neck service.
Li L; Tikka T; Morton C; Chan C; Hayois L; Henderson M; Hastie C; Lee L; Porteus L; Nixon I
J Laryngol Otol; 2023 Jul; 137(7):763-768. PubMed ID: 35995755
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus disease 2019 pandemic telephone two-week-wait referrals in head and neck cancer - how safe were they?
Lau KL; Wilson M; Oozeer N; Cocks H
J Laryngol Otol; 2024 Mar; 138(3):321-324. PubMed ID: 37403606
[TBL] [Abstract][Full Text] [Related]
7. The impact of coronavirus disease 2019 on suspected head and neck cancer two-week-wait referrals.
Bhamra N; Gorman B; Arnold W; Rajah A; Jolly K; Nieto H; Fussey J; Liew L
J Laryngol Otol; 2022 Mar; 136(3):248-251. PubMed ID: 34158135
[TBL] [Abstract][Full Text] [Related]
8. Impact of coronavirus disease 2019 on head and neck urgent suspected cancer referral pathways in rural Wales.
Abelardo E; Gravelle R; Scannell M; Shastri P; Vandekar M; Davies G; Volpini L; Prabhu V
J Laryngol Otol; 2022 Jun; 136(6):540-546. PubMed ID: 35357276
[TBL] [Abstract][Full Text] [Related]
9. Two week wait referral criteria - heading in the right direction?
Gao C; Qin C; Freeman S; Oskooee N; Hughes J
J Laryngol Otol; 2019 Aug; 133(8):704-712. PubMed ID: 31370911
[TBL] [Abstract][Full Text] [Related]
10. Outcomes for patients referred urgently with suspected head and neck cancer.
Hobson JC; Malla JV; Sinha J; Kay NJ; Ramamurthy L
J Laryngol Otol; 2008 Nov; 122(11):1241-4. PubMed ID: 18371234
[TBL] [Abstract][Full Text] [Related]
11. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Omakobia E; Sood S; Glore RJ
J Laryngol Otol; 2020 Aug; 134(8):684-687. PubMed ID: 32758307
[TBL] [Abstract][Full Text] [Related]
12. The lasting impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Khan A; Omakobia E; Sood S
J Laryngol Otol; 2023 May; 137(5):537-540. PubMed ID: 36789959
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors.
Tikka T; Kavanagh K; Lowit A; Jiafeng P; Burns H; Nixon IJ; Paleri V; MacKenzie K
Clin Otolaryngol; 2020 May; 45(3):380-388. PubMed ID: 31985180
[TBL] [Abstract][Full Text] [Related]
14. Rhinology in the COVID-19 era: Our experience from a rhinology tertiary referral hospital and implications for future practice.
Magill JC; Unadkat S; Bullock E; Ferguson MS; Rennie C; Grant WE; Saleh HA
Clin Otolaryngol; 2021 Jan; 46(1):96-100. PubMed ID: 33405322
[No Abstract] [Full Text] [Related]
15. Accuracy of the Head and Neck Cancer Risk Calculator in identifying maxillofacial malignancies.
Simpson CD; Hennigan M; Morrison J
Br J Oral Maxillofac Surg; 2023 Jun; 61(5):356-361. PubMed ID: 37169617
[TBL] [Abstract][Full Text] [Related]
16. North East London coronavirus disease 2019 protocol for diagnostics in two-week wait head and neck cancer patients.
Warner E; Scholfield DW; Adams A; Richards P; Ali S; Ahmed J; Ghufoor K
J Laryngol Otol; 2020 Aug; 134(8):680-683. PubMed ID: 32613916
[TBL] [Abstract][Full Text] [Related]
17. Patient Satisfaction With the Head and Neck Cancer Telephone Triage Service During the COVID-19 Pandemic.
Zhu Y; Chen Z; Ding A; Walter H; Easto R; Wilde A
Cureus; 2021 Sep; 13(9):e18375. PubMed ID: 34729263
[TBL] [Abstract][Full Text] [Related]
18. Symptom-based remote assessment in post-treatment head and neck cancer surveillance: A prospective national study.
Zhang H; Hardman JC; Tikka T; Nankivell P; Mehanna H; Paleri V;
Clin Otolaryngol; 2022 Sep; 47(5):561-567. PubMed ID: 35634790
[TBL] [Abstract][Full Text] [Related]
19. Outcome of two-week head and neck cancer pathway for the otolaryngology department in a tertiary centre.
Mettias B; Charlton A; Ashokkumar S
J Laryngol Otol; 2021 Oct; 135(10):869-873. PubMed ID: 34348805
[TBL] [Abstract][Full Text] [Related]
20. A review of telephone consultations for head and neck cancer follow up: a patient satisfaction survey.
Stewart R; Collins L; Kerr B; Gray G; Devlin B; Black M; Ullah R
J Laryngol Otol; 2021 Sep; 135(9):815-819. PubMed ID: 34294168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
